Showing all 2 results
Bosentan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in moisture-resistant Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Bosentan (as Monohydrate) USP/Ph.Eur. 62.5 mg The Initiation Unit: Utilized for the first 4 weeks of therapy to assess patient tolerance and liver response. Bosentan (as Monohydrate) USP/Ph.Eur. 125 mg The Maintenance Payload: The standardized therapeutic dose for long-term management of PAH and exercise capacity improvement. Excipients Proprietary Matrix Controlled Disintegration System: Engineered to ensure a predictable pharmacokinetic profile, matching the innovator brand’s $T_{max}$ (time to peak concentration).
